Medical Oncology Training Pathway

How to become a medical oncologist in Australia — RACP Basic Physician Training, the Divisional exams, the competitive jump onto Advanced Training in Medical Oncology, the clinical-trials and systemic-therapy requirements, how it differs from radiation oncology and haematology, and what the published ATO data shows medical oncologists earn.

There are two bottlenecks, not one: getting onto Basic Physician Training, then — after passing both Divisional exams — winning an accredited Advanced Training post. Selection is run by hospitals, networks and states, not the RACP, and no national scored rubric with percentage weightings is published. Worth knowing: medical oncology is a separate pathway from radiation oncology (a different college, RANZCR) and from haematology — and it's largely a cognitive, clinical-trials-rich specialty rather than a procedural one.

Why medical oncology

You diagnose and manage cancer with systemic therapy — chemotherapy, immunotherapy, targeted and hormonal therapy — across solid-tumour streams (breast, lung, gastrointestinal, genitourinary, melanoma, gynaecological and more). The work is largely cognitive and outpatient: complex decision-making, long-term and end-of-life care, and a heavy multidisciplinary-team component with surgeons, radiation oncologists, pathologists and palliative care. Clinical trials are central — many units run early- and late-phase trials, and trials competence is a curriculum requirement. There's real acute work too: febrile neutropenia, oncologic emergencies and the inpatient care of unwell cancer patients, though the procedural load is light. It suits people drawn to complex, evidence- and trials-driven decision-making, who value long-term therapeutic relationships and multidisciplinary care, who are comfortable with serious illness and end-of-life conversations, and who want a largely cognitive (rather than procedural) physician specialty — and who are prepared for a long pathway with two competitive entry points and an expectation of research output to be competitive for advanced training.

• Draws: Intellectually rich, evidence- and clinical-trials-driven practice, Largely cognitive and outpatient, with a light procedural load, Rapidly evolving field (immunotherapy, targeted and precision oncology), Earnings around or slightly above the physician average (ATO data).
• Trade-offs: Two competitive bottlenecks (BPT, then Advanced Training), No national selection rubric to optimise against, Emotionally demanding — serious illness, end-of-life care, Long pathway (~6 years college training) with research expected to compete.
• Subspecialties: Breast, lung, GI, GU, melanoma & other tumour streams, Early-phase / Phase I clinical trials & drug development, Precision oncology & molecular tumour boards, Adolescent & young-adult oncology, Cancer survivorship & supportive care, Dual training in clinical haematology (separate program).

The training pathway

The same fellowship, two very different timelines. The fast route assumes everything goes right; most people land on the realistic one.

How competitive is it?

Medical oncology is competitive, but the hard numbers are limited and a precise success rate isn't published. The RACP does not publish a national applicant-to-offer ratio for medical oncology Advanced Training, and none was located from any state body — selection is employment-based and run by hospitals, networks and states. On workforce, the (now dated) 2016 National Health Workforce Dataset factsheet counted 568 medical oncologists in Australia, of whom about 88.7% were clinicians and 29.8% worked in the private sector, about 60.9% male with an average clinician age of about 48, and about 83.9% in a major city — a national ratio of about 2.1 per 100,000. More recent NSW data put the 2019 NSW workforce at 236 specialists (186 clinical) with 68 advanced trainees, and the NSW modelling concluded the state would have enough new fellows to meet need by 2035 with no required increase in trainee numbers — a notably different picture from older national MOGA modelling (from 2009/2014) that described a shortfall. A 2018 MOGA survey found most advanced trainees were concerned about future job prospects, but that reflects post-Fellowship job sentiment, not an entry-competition ratio, so we don't present it as one. The current national gender split, average age and a current national headcount aren't compiled here from a verifiable up-to-date source.

Unaccredited time: There's no formal 'unaccredited' tier as in surgery, but medical oncology Advanced Training is competitive enough that many do extra unaccredited oncology/registrar time and research after the Divisional exams to build a competitive CV before a successful application. No required or typical number of years is published.

Sources: RACP — Medical Oncology Advanced Training, MOGA — Medical Oncology Group of Australia, Department of Health — Medical Oncology Workforce factsheet (NHWDS 2016), NSW Health — Medical Oncology workforce modelling (2019 data).

Selection criteria & how to apply

Medical oncology has two competitive entry points, and there is no national scored round with published percentage weightings — so this section works differently from the surgical pathways (and from neurology, the one physician subspecialty that does publish a national rubric). First you compete for a Basic Physician Training post: you apply directly to a hospital or BPT network (the RACP sets standards but does not recruit or select trainees), and selection is state/network-based. After three years of BPT you must pass both Divisional exams. Then comes the harder step: a separate, competitive, employment-based application for an accredited medical oncology Advanced Training post. The RACP again does not run this — selection is by hospitals, networks and states. Victoria and Tasmania use a PMCV two-sided preference match, in which candidates and health services rank each other and a shortlist is interviewed; the published inputs are the CV/application, three referees (two consultants plus a nurse-unit manager for new applicants) and the interview. NSW and Queensland run network/statewide recruitment, and the western states recruit through their teaching hospitals. Crucially, none of these publishes numeric scoring weightings for medical oncology, and the PMCV match states that 'overall ranking will not be available to candidates.' The components below are therefore shown as qualities assessed, not as percentages:

Key documents: RACP — Medical Oncology Advanced Training, RACP — Entry into Basic Training, PMCV — Medical Oncology Match (Vic/Tas), MOGA — Trainees.

How it works, state by state

How to optimise your application

• Pass the Divisional exams cleanly (tied to Eligibility gate, start during BPT) — Both the Divisional Written and Clinical Examinations must be passed to be eligible for Advanced Training — a first-time pass keeps you on timeline and frees time for research and oncology terms.
• Build research and clinical-trials exposure (tied to Research & other achievements, start PGY2 onwards) — Research and trials involvement are core differentiators in a trials-heavy specialty — aim for oncology rotations, publications, presentations and trials experience early.
• Line up strong (ideally oncology) referees (tied to References, start BPT / post-exam) — The PMCV match requires three referees (including a nurse-unit manager for new applicants) and other states require referee reports — sustained oncology terms let you field strong, relevant referees.
• Prepare for the interview (tied to Interview, start pre-application) — Shortlisted applicants attend an interview — practise structured, case-based answers and be ready to discuss research, clinical-trials experience and motivation.

Key documents & official links

• RACP — Medical Oncology Advanced Training
• RACP — Entry into Basic Training
• RACP — Divisional Written Examination (past results)
• RACP — Divisional Clinical Examination
• MOGA — Medical Oncology Group of Australia (education & trainees)
• COSA — Clinical Oncology Society of Australia
• RACP — Standard Specialist Assessment Pathway (IMGs)

FAQ

Trained overseas? (IMG pathway)

Related specialties

Last reviewed 2026-06-01.